214 related articles for article (PubMed ID: 2491470)
1. A single night-time dose of famotidine is equivalent to ranitidine in decreasing 24-hour gastric acidity in asymptomatic duodenal ulcer subjects.
Thomson AB; Pinchbeck BR; Kirdeikis J; Zuk L; Marriage B; Prat A
Aliment Pharmacol Ther; 1989 Apr; 3(2):199-210. PubMed ID: 2491470
[TBL] [Abstract][Full Text] [Related]
2. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
4. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
[TBL] [Abstract][Full Text] [Related]
5. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
6. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
Fullarton GM; Macdonald AM; McColl KE
Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four-hour intragastric acidity in duodenal ulcer patients during dosing with placebo, and 150 mg ranitidine twice or four times daily.
Howden CW; Tsai HH; Reid JL
Aliment Pharmacol Ther; 1989 Jun; 3(3):253-8. PubMed ID: 2520620
[TBL] [Abstract][Full Text] [Related]
8. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
9. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
[TBL] [Abstract][Full Text] [Related]
10. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
Thomson AB
Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
[TBL] [Abstract][Full Text] [Related]
11. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.
Lanzon-Miller S; Pounder RE; Hamilton MR; Ball S; Chronos NA; Raymond F; Olausson M; Cederberg C
Aliment Pharmacol Ther; 1987 Jun; 1(3):239-51. PubMed ID: 2979226
[TBL] [Abstract][Full Text] [Related]
13. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ranitidine 300 mg twice daily, 300 mg at night and placebo on 24-hour intragastric acidity of duodenal ulcer patients.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Kaufmann D; Mappes A; Heim J; Röhmel J
Aliment Pharmacol Ther; 1987 Jun; 1(3):217-23. PubMed ID: 2979224
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
16. A prospective comparison of the effects of placebo, ranitidine and highly selective vagotomy on 24 h ambulatory intragastric pH in patients with duodenal ulcer.
Rogers MJ; Holmfield JH; Primrose JN; Gledhill T; Johnston D
Br J Surg; 1988 Oct; 75(10):961-5. PubMed ID: 3219542
[TBL] [Abstract][Full Text] [Related]
17. The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
Lanzon-Miller S; Pounder RE; Ball SG; Dalgleish DJ; Coward J; Jackson AO
Scand J Gastroenterol; 1988 Mar; 23(2):244-50. PubMed ID: 3283919
[TBL] [Abstract][Full Text] [Related]
18. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of two cimetidine regimens on 24-hour intragastric acidity in patients with asymptomatic duodenal ulcer.
Mahachai V; Walker K; Jamali F; Navert H; Cook D; Symes A; Thomson AB
Clin Ther; 1984; 6(3):259-81. PubMed ID: 6373006
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
